0001231919-23-000044.txt : 20230706 0001231919-23-000044.hdr.sgml : 20230706 20230706160443 ACCESSION NUMBER: 0001231919-23-000044 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230706 DATE AS OF CHANGE: 20230706 EFFECTIVENESS DATE: 20230706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-486102 FILM NUMBER: 231073584 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 D 1 primary_doc.xml X0708 D LIVE 0001636282 Aeglea BioTherapeutics, Inc. 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX TEXAS 78746 (512) 942-2935 DELAWARE None None Corporation true Jonathan Alspaugh c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Executive Officer Cameron Turtle c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Executive Officer Cortney Caudill c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Executive Officer Russell J. Cox c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Director Peter Harwin c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Director Michael Henderson c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Director Tomas Kiselak c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Director Alison Lawton c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Director Ivana Magovcevic-Liebisch c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Director Hunter C, Smith c/o Aeglea BioTherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX TEXAS 78746 Director Biotechnology Decline to Disclose 06b false 2023-06-26 false true true 0 Jefferies LLC 2347 None None 520 Madison Avenue New York NY NEW YORK 10022 CA CALIFORNIA CO COLORADO CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NY NEW YORK PA PENNSYLVANIA false Cowen and Company, LLC 7616 None None 599 Lexington Avenue New York NY NEW YORK 10022 CA CALIFORNIA CO COLORADO CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NY NEW YORK PA PENNSYLVANIA false Stifel, Nicolaus & Company, Incorporated 793 None None 787 Seventh Avenue New York NY NEW YORK 10019 CA CALIFORNIA CO COLORADO CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NY NEW YORK PA PENNSYLVANIA false Guggenheim Securities, LLC 40638 None None 330 Madison Avenue New York NY NEW YORK 10017 CA CALIFORNIA CO COLORADO CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NY NEW YORK PA PENNSYLVANIA false 210000248 210000248 0 false 41 0 12600015 0 false Aeglea BioTherapeutics, Inc. /s/ Jonathan D. Alspaugh Jonathan D. Alspaugh President & Chief Financial Officer 2023-06-28